Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    OpGen

    MCap

    USD69m

    Last close

    USD4.60

    ▲ −0.92 (−16.67%)

    Percheron Therapeutics

    MCap

    AUD5m

    Last close

    AUD0.00

    ▲ 0.00 (33.33%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Recce Pharmaceuticals – executive interview

Recce Pharmaceuticals – executive interview

Recce Pharmaceuticals — 6 videos in collection

More on this equity

Recce Pharmaceuticals is an Australian company developing its novel, broad-spectrum synthetic polymer anti-infective drugs for the treatment of several infectious diseases, including sepsis, burn wound infections, urinary tract infections/urosepsis and diabetic foot infections.
In this interview, CEO James Graham describes the company’s latest developments in advancing its lead compound RECCE® 327 (R327) to treat complex drug-resistant infections. He discusses Recce’s recent human data on the intravenous R327 formulation targeting urinary tract infections and sepsis/urosepsis, as well as upcoming clinical trial strategies in these areas. James also elaborates on the topical R327 formulation’s progress in skin and skin-structure infections and Recce’s plans to start a registrational Phase III trial in Indonesia for diabetic foot infections in the coming months.

< Previous
Next >

You may also be interested in these:

Healthcare

Recce Pharmaceuticals – equity proposition

Healthcare

Recce Pharmaceuticals – Investor Webinar March 2026
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.